Use and effect of short acting β-agonist trials in children aged 2–59 months presenting with respiratory symptoms in low-, middle-, and high-income, primary care settings.
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://figshare.com/articles/dataset/Use_and_effect_of_short_acting_-agonist_trials_in_children_aged_2_59_months_presenting_with_respiratory_symptoms_in_low-_middle-_and_high-income_primary_care_settings_/10262207
下载链接
链接失效反馈官方服务：
资源简介：
Use and effect of short acting β-agonist trials in children aged 2–59 months presenting with respiratory symptoms in low-, middle-, and high-income, primary care settings.
短效β-激动剂（short acting β-agonist）试验在低、中、高收入经济体基层医疗环境中，针对因呼吸道症状就诊的2至59月龄儿童群体的应用与效果
创建时间：
2019-11-06
